/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.41%
Natural Gas
-4.98%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.57%
VIX
N/A
Economic Calendar
EUR/USD
-0.41%
Natural Gas
-4.98%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.57%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Euro Area Sovereign Credit: Some Ratings Under Pressure as Fiscal Challenges Mount
about 21 hours ago
CB Consumer Confidence Drops To 97.0, Missing Analyst Expectations
about 19 hours ago
Germany: Economic Outlook Stable Despite Near-term Stagnation and Fiscal Challenges
about 22 hours ago
Coca-Cola Tops Q1 Forecasts, McDonald’s Faces Middle East Issues
about 24 hours ago
MicroStrategy Bitcoin (BTC) Holdings Hits $13.6 Billion after Latest Purchase
1 day ago
German Retail Sales Rise by 1.8% in March on Food Sales
1 day ago
Crude Oil News Today: Ceasefire Talks, Rising US Inventories Weigh on Prices
27 minutes ago
Dogecoin Price Forecast: Will DOGE Fall Below $0.10 in May 2024?
about 1 hour ago
The Market News Today: Investors Bracing for Uncertain Fed Response to Inflation
about 1 hour ago
EUR/USD, GBP/USD, DXY Price Forecast: Fed’s 5.50% Rate to Shape Markets
about 3 hours ago
Silver (XAG) Daily Forecast: Buying Over $26.46 Amid Middle East Tensions
about 4 hours ago
A New Stage of Bitcoin’s Decline
about 4 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
ARWR
profile
Arrowhead Pharmaceuticals Inc.
Follow
ARWR
(
Nasdaq - US
)
N/A
22.63
-0.50 (-2.16%)
in
:
usd
•
As of: Apr 30, 2024 15:59
UTC -4
Open
22.70
High
23.16
Low
22.60
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Arrowhead Pharmaceuticals Inc.
CEO
Christopher Anzalone
Headquarters
177 e. colorado blvd, suite 700
pasadena, ca 91105, united states
Auditor
Rose, Snyder & Jacobs LLP
Employees
525
Share Holders
97
Website
www.arrowheadpharma.com
Industry
biotechnology
Sector
health technology
Company Overview
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Arrowhead Pharmaceuticals Inc.
Statistics
Valuation Measures
Market Capitalization
2
2.80B
Enterprise Value
2.75B
Enterprise Value/EBITDA
(ttm)
-9.50
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
15.68
Price to Sales
(ttm)
15.08
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
100.00%
Operating Margin
(ttm)
-163.32%
Profit Margin
(ttm)
-1260.05%
Return on Equity
(ttm)
-90.77%
Return on Invested Capital
(ttm)
-133.60%
Return on Assets
(ttm)
-38.56%
Income Statement
Revenue
(ttm)
181.74M
Revenue Per Share
(ttm)
1.47
Gross Profit
(ttm)
181.74M
EBITDA
(ttm)
3
-288.89M
Net Income Avi to Common
(ttm)
-296.81M
Diluted EPS
(ttm)
-2.78
Share Statistics
Beta (5Y Monthly)
0.71
52-Week Change
-36.65%
S&P500 52-Week Change
24.15%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
123.90M
Dividend Yield
0.00%
Float
4
118.32M
%
Held by Insiders
4.50%
%
Held by Institutions
62.61%
Balance Sheet
Total Cash
(mrq)
220.28M
Total Cash Per Share
(mrq)
1.78
Total Debt
(mrq)
0.00
Total Debt/Equity
(mrq)
0.00%
Current Ratio
(mrq)
3.73%
Quick Ratio
(mrq)
3.73%
Book Value Per Share
(mrq)
1.62
Cash Flow
Operating Cash Flow Per Share
(ytd)
-1.10
Free Cash Flow
(ytd)
-186.50M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker